Literature DB >> 15227354

Effects of isosorbide dinitrate on rheumatic and non-rheumatic mitral regurgitation.

M K Jeang1, L J Petrovich, A V Adyanthaya, J Alexander.   

Abstract

Isosorbide dinitrate was given to seven patients with isolated mitral regurgitation (three cases of rheumatic origin, four non-rheumatic) to assess its hemodynamic effects. The pulmonary capillary pressure, left ventricular end-diastolic pressure, left ventricular end-diastolic volume index, and the aortic pressure were all significantly reduced. The heart rate was significantly increased, while the systemic vascular resistance and the left ventricular contractility index were unchanged. The regurgitant flow increased by an average of 72.2% in the rheumatic group, but decreased by an average of 4.8% in the non-rheumatic group (p < 0.05). The forward cardiac output decreased slightly in both groups, but the difference was not significant (NS). It appears that isosorbide dinitrate has a more detrimental effect on cases of mitral regurgitation of rheumatic origin than on those of non-rheumatic origin. We suggest the difference in the responses is a consequence of the dynamic nature of the regurgitant orifice in the non-rheumatic group and the static nature of the orifice in the rheumatic group.

Entities:  

Year:  1986        PMID: 15227354      PMCID: PMC324676     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  11 in total

1.  Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.

Authors:  D J Goodman; R M Rossen; E L Holloway; E L Alderman; D C Harrison
Journal:  Circulation       Date:  1974-11       Impact factor: 29.690

2.  Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

Authors:  K Chatterjee; W W Parmley; H J Swan; G Berman; J Forrester; H S Marcus
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

3.  Left ventricular volume and mass from single-plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods.

Authors:  J W Kennedy; S E Trenholme; I S Kasser
Journal:  Am Heart J       Date:  1970-09       Impact factor: 4.749

4.  Pathophysiology of valvar heart disease. The dynamic nature of mitral valve regurgitation.

Authors:  G L Pierpont; R C Talley
Journal:  Arch Intern Med       Date:  1982-05

5.  Response of the left ventricle to nitroglycerin in patients with and without mitral regurgitation.

Authors:  A D Sniderman; D G Marpole; W H Palmer; E L Fallen
Journal:  Br Heart J       Date:  1974-04

6.  Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.

Authors:  J Mehta; R L Feldman; W W Nichols; C J Pepine; C R Conti
Journal:  Br Heart J       Date:  1980-05

7.  Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area.

Authors:  C Yoran; E L Yellin; R M Becker; S Gabbay; R W Frater; E H Sonnenblick
Journal:  Circulation       Date:  1979-07       Impact factor: 29.690

8.  Beneficial effects of hydralazine in severe mitral regurgitation.

Authors:  B H Greenberg; B M Massie; B H Brundage; E H Botvinick; W W Parmley; K Chatterjee
Journal:  Circulation       Date:  1978-08       Impact factor: 29.690

9.  Mechanism of reduction of mitral regurgitation with vasodilator therapy.

Authors:  C Yoran; E L Yellin; R M Becker; S Gabbay; R W Frater; E H Sonnenblick
Journal:  Am J Cardiol       Date:  1979-04       Impact factor: 2.778

10.  Effect of nitroglycerin ointment on hemodynamics in patients with mitral insufficiency.

Authors:  L Gould; C V Reddy; B Zen; B K Singh
Journal:  Angiology       Date:  1980-10       Impact factor: 3.619

View more
  1 in total

1.  Is there a role for combination anti-remodelling therapy for heart failure secondary to chronic rheumatic mitral regurgitation?

Authors:  Ruchika Meel; Ferande Peters; Elena Libhaber; Mohammed R Essop
Journal:  Cardiovasc J Afr       Date:  2017 Sep/Oct       Impact factor: 1.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.